Searchable abstracts of presentations at key conferences in endocrinology

ea0010p63 | Reproduction | SFE2005

Male hypogonadism caused by isolated LH deficiency: from pathology to physiology

Chattopadhyay A , Al-Othman A , Bayoumy H , Moharib N , Nazmi N , Al-Alwadi Q

The development of Leydig cells and steroidogenesis are controlled by activation of luteinizing hormone (LH) receptors by placental HCG during intrauterine life and by pituitary LH after birth. Naturally occurring isolated LH deficiency in man thus provide useful information to understand the intriguing role of this gonadotrophin.The patient was a 23 yr-old man from Afghanistan with a 46, XY karyotype. He presented with absent pubertal development and pr...

ea0016p225 | Diabetes and cardiovascular diseases | ECE2008

Circulating endotoxin as a potential biomarker and mediator of inflammation: influenced by diabetic therapies

Al-Daghri Nasser , Al-Rubeaan Khalid , Al-Attas Omar , da Silva Nancy , Sabico Shaun , Kumar Sudhesh , Mc Ternan Philip , Harte Alison

Recent studies suggest that endotoxin from gut flora, may be key to development of inflammation by stimulating the secretion of an adverse cytokine profile from adipose tissue. The study investigated the relationship between endotoxin and various metabolic parameters of diabetic patients to determine if anti-diabetic therapies exerted a significant effect on endotoxin levels and adipocytokine profiles of T2DM subjects. Fasting blood samples were collected from consenting Saudi...

ea0077p256 | Thyroid | SFEBES2021

Audit of Liothyronine Prescribing at the University Hospitals of Leicester (UHL) NHS Trust

Al Jumaah Ali , Levy Miles , Bhake Ragini , Reddy Narendra

Introduction: Levothyroxine is the first choice treatment for patients with hypothyroidism However, some people would continue to have symptoms of thyroid disease despite biochemical control on levothyroxine. Others might be intolerant to levothyroxine.Aim: The aim of this audit is to evaluate UHL endocrinology practice against local and national guidelines with regards to prescribing and monitoring of liothyronine treatment in 2019.<p class="abstext...

ea0052p30 | (1) | UKINETS2017

Outcomes of surgical and endoscopic resection of duodenal NETs: a systematic review of the literature

Al-Shakhshir Sarah , Dasari Bobby VM , Shah Tahir

Introduction: Duodenal neuro endocrine tumors (d-NETs) comprise about 2% of all NETs. Treatment of d-NETs involves resection of the tumour either by endoscopic or surgical resection. Local resection of the lesion is usually a safer option compared to a more radical pancreaticoduodenectomy. However, inadequate clearance by local resection might result in recurrent disease and reduce the overall survival. There is no current available evidence regarding the extent of resection.<...

ea0081p107 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

The relation between insulin resistance and both growth hormone and insulin-like growth factor (IGF-1) levels in a sample of Iraqi patients with type 2 diabetes

Mohammed Alrubyae Hasanain , Al-Saffar Araz , Allehibi Khalid

Introduction Background: Over the last decade, scientific attention has been drawn to the potential role of Growth hormone (GH) and Insulin Like Growth Factor-1 (IGF-1) in the pathogenesis and progression of T2DM. Both hormones are interrelated but exert variable effect on glucose homeostasis. While GH increases blood glucose level, IGF-1 maintain insulin secretion and enhance insulin sensitivity.Methods: A cross sectional study conducted in the National...

ea0081ep421 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

The effects of Semaglutide on glycaemic control and weight, in type two diabetic patients, in our diabetic day center

Al-Shaibany Azhar , Mc Cabe Olivia , Shabaht Shah

Introduction: Type two diabetes is characterized by a chronic metabolic state (obesity, high blood pressure, and dyslipidemia) and insulin resistance. There is insufficient pancreatic insulin production and ineffective use of the produced insulin resulting in abnormally high blood glucose levels (hyperglycaemia). Metabolic syndrome and diabetes are associated with increased cardiovascular risk, reduced life expectancy and a reduction in quality of life. Glucagon-like peptide 1...

ea0050p042 | Bone and Calcium | SFEBES2017

LC-MS/MS measurement of parathyroid hormone PTH (1-34): Use in studying oral PTH (1-34) administration and possible diagnostic application in pseudohypoparathyroidism

Al-Riyami Sulaiman , Tang Jonathan , Galitzer Hillel , Fraser William

Background: Teriparatide PTH(1-34) is an osteoanabolic agent used in the treatment of osteoporosis. Measurement of PTH(1-34) can be useful in osteoporosis treatment and in the diagnosis of pseudohypoparathyroidism (PHP) by confirming administration of PTH(1-34)Aims: 1) To assess PTH(1-34) profiles obtained using standard Forsteo treatment compared to using a novel oral administration. 2) To confirm the PTH(1-34) in a PHP patient re...

ea0050p042 | Bone and Calcium | SFEBES2017

LC-MS/MS measurement of parathyroid hormone PTH (1-34): Use in studying oral PTH (1-34) administration and possible diagnostic application in pseudohypoparathyroidism

Al-Riyami Sulaiman , Tang Jonathan , Galitzer Hillel , Fraser William

Background: Teriparatide PTH(1-34) is an osteoanabolic agent used in the treatment of osteoporosis. Measurement of PTH(1-34) can be useful in osteoporosis treatment and in the diagnosis of pseudohypoparathyroidism (PHP) by confirming administration of PTH(1-34)Aims: 1) To assess PTH(1-34) profiles obtained using standard Forsteo treatment compared to using a novel oral administration. 2) To confirm the PTH(1-34) in a PHP patient re...

ea0086p276 | Reproductive Endocrinology | SFEBES2022

Is there a consensus for Management of Hormone Replacement for Males and Females with Hypogonadism in the UK? SfE national survey

Al-Sharefi Ahmed , Quinton Richard , Turner Helen E

Background: Optimization of sex hormone replacement therapy (SHRT) is essential in long-term management of patients with hypogonadism. However, approaches to formulations of therapy, dose change (if any), monitoring of adequacy of therapy and safety are not standardised.Objectives: The survey aimed to establish the approach to management of SHRT for male and female hypogonadism.Methods: Online survey, live for 4 weeks (1/11/2021) d...

ea0089c7 | Clinical – Chemo/SSA/Biologics | NANETS2022

Risk of Myelodysplastic Syndrome/Acute Leukemia with Sequential Capecitabine/Temozolomide and 177Lu-Dotatate

MPH Taymeyah Al-Toubah , MD Eleonora Pelle , MD Jonathan Strosberg

Background: The treatment landscape for neuroendocrine tumors includes alkylating-agent chemotherapy and peptide receptor radiotherapy (PRRT) with 177Lu-Dotatate. The risk of MDS/AML associated with 177Lu-Dotatate is approximately 2-3%. Several small prior studies have suggested substantially higher rates of MDS/AML (approximately 10%) in patients who have also received alkylating agent chemotherapy with streptozocin or temozolomide, either combined with PRRT or sequentially. ...